Prevalence of analgesic consumption in the northern of Portugal;Estudo C.A.N.PO. Prevalência do consumo de analgésicos no norte de Portugal

Acta Reumatologica Portuguesa

Volumn 35, Issue 4, 2010, Pages 434-440

  Reis, Alexandra ^a   Tudela, Mariana ^b   Jorge, Poliana ^c   Novais, Carmo ^d   Fonseca, Clara ^e  

^a I Vila Nova de Famalicão   (Brazil)

^b ULS Matosinhos   (Brazil)

^c Centrode Saúde de Leça da Palmeira ^*  (Brazil)

^d USF Lagoa   (Brazil)

^e Vila Nova de   (Brazil)

Author keywords

Analgesics; Consumption; Family medicine; Portugal; Prevalence; Primary care

Indexed keywords

ANALGESIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; DRUG UTILIZATION; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; PORTUGAL; STATISTICS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALGESICS; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PORTUGAL; YOUNG ADULT;

EID: 79251487025     PISSN: 0303464X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent Patterns of Medication Use in the Ambulatory Adult Population of the United States. JAMA 2002;287:337-344.
2. Lapeyre-Mestre M, Chastan E, Louis A, Montastruc JL. Drug Consumption in Workers in France: A Comparative Study at 10 Year Interval (1996 versus 1986). J ClinEpidemiol 1999;52:471-479.
3. Paulose-Ram R, Hirsch R, Dillon C, Gu Q. Frequent monthly use of selected non-prescription non-narcotic analgesics among U.S. adults. Pharmacoepidemiology and drug safety 2005;14:257-266.
4. Antonov K, Isacson D. Use of Analgesics in Sweden-The importance of Sociodemographic factors, physical fitness, health and health-related factors, and working condicions. Pergamon 1996;42:1473-1481.
5. Motola D, Vaccheri A, Silvani MC, et al. Pattern of NSAID use in the Italian general population: a ques-tionnaire-based survey. Eur J Clin Pharmacol 2004;60:731-738.
6. David D. Chronic Pain Prevalence and Analgesic prescribing in a General Medical Population. Journal of Pain and Symptom Management 2002;23:131-137.
7. Marques FB, Ribeiro CAF. Consumo de analgésicos no ambulatório: resultados de um estudo piloto de avaliação de prevalências. Inform-Terap 1998;7:6-8.
8. Estatística do medicamento 2004: 58-64 Disponível em: URL:http://www.infarmed.pt [acedido em 15.09.2007].
9. American Pain Society [serial online]; Pain: Current Understanding of Assessment, Management and Treatments. Disponível em: http://www.ampainsoc.org/ce/npc/III/a_pharmacologic.htm.
10. Edições Simposium, Lda. Enciclopédia de especiali dades farmacêuticas portuguesas Simposium tera pêutico(; 2005.
11. Sachs CJ. Oral Analgesics for Acute Nonspecific Pain. American Family Physician 2005 Mar; 1: 71.
12. Laporte JR, Carné X, Vidal X, Moreno V, Juan J. Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs. The Lancet 1991;337:85-89.
13. Sturkenboom MCJM, Romano F, Simon G, et al. The iatrogenic costs of NSAID therapy: A population study. Arthritis care & Research 47:132-140.
14. Pilotto A, Franceschi M, Gioacchino L, DiMario F NSAID and Aspirin Use by the Elderly in General Practice. Drugs Aging 2003;20:701 -710.
15. Moore N, Charlesworth A, Ganse EV, et al. Risk fac tors for adverse events in analgesic drug users: results from the PAIN study. Pharmacoepidemiology and drug safety 2003;12:601-610.
16. Cullen DJE, Hawkey GM, Greenwood DC, et al. Peptic ulcer bleeding in the elderly: relative roles of Helicobacter pylori and non-steroidal anti-inflammatory drugs. Gut 1997;41:459-462.
17. MacDonal TM, Morant SV, Robinson GC, et al. Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study. BMJ 1997;315:1333-1337.
18. Rodríguez LA, Hernández-Díaz S. Risk of Uncomplicated Peptic Ulcer among Users of Aspirin and Nonaspirin Nonsteridal Antiinflammatory Drugs. Am J Epidemiol2004;159:23-31.
19. Tomida T, Ochi T, Sugano K, Uemura S, Makuch RW. Systematic review of NSAID-induced adverse reactions in patients with rheumatoid arthritis in Japan. Mod Rheumatol 2003;13:143-152.
20. McLaughlin JK, Iipworth L, Chow WH, Blot WJ. Anal gesic use and chronic renal failure: A critical review of the epidemiologic literature. Kidney International 1998;54:679-686.
21. Mcgettigan P, Platona A, Henry D. Renal and Cardio vascular toxicity of non-steroidal anti-inflammatory drugs. Inflammopharmacology 2000;8:1-18.
22. Lindeman RD. Should the sale of analgesic mixtures and non-steroidal anti-inflammatory agents (NSAIDs) continue to be allowed as allowed as over-the-counter (OTC) medications? Geriatric Nephrology and Urology 1999;9:3-4.
23. Kohlhagen J, Katrib A, Stafford L, Brown MA, Edmonds J. Does regular use of non-steroidal anti-inflammatory drugs increase the risk of renal disease? Nephrology 2002;7:5-11.
24. Gøtzshe PC. Extracts from "Clinical Evidence": Non-steroidal anti-inflammatory drugs. BMJ 2000;320: 1058-1061.
25. Mukherjee D, Nissen SE, Topol EJ. Risk of Cardiovas cular Events Associated With Selective COX-2 Inhibitors. JAMA 2001;286:954-959.
26. Lee WM. Drug-induced Hepatotoxicity. The New England Journal of Medicine 1995;33:1118-1127.
27. Schiødt FV, Rochling FA, Casey DL, Lee WM. Acetominophen toxicity in an urban county hospital. The New Engalnd Journal Of Medicine 1997;337: 1112-1116.
28. Gomes E, Cardoso MF, Praca F, Gomes L, Marino E, Demoly P. Self-reported drug allergy in a general adult Portuguese population. Clin Exp Allergy 2004;34:1597-1601.
29. Roberts II LJ, Morrow JD. Analgesic-antipyretic and antiinflammatory agents and drugs employed in treatment of gout. In: Goodman, Gilman's, editors. The Pharmacological Basin of Therapeutics. 9th ed.p.521-555.
30. Singh G, Tradafilopoulus G. Epidemiology of NSAID-induced gastrointestinal complications (Review). J Rheumatol 1999;56:18-24.
31. Paulose-Ram R, Hirsch R, Dillon C, Losonczy K, Cooper M, Ostchega Y. Prescription and non-prescription analgesic use among the US adult population: results from the third National Health and Nutricion Examination Survey (NHANESIII). Pharmacoepidemiology and drug safety 2003;12:315-326.
32. Turk DC, Okifuji A. Does sex make a difference in the prescription of treatments and the adaptation to chronic pain by cancer and non-cancer patients? Pain 1999;82:139-148.
33. Helin-Salmivaara A, Klaukka T, Huupponen R. Heavy users of non-steroidal anti-inflammatory drugs: a nationwide prescription database study in Finland. Eur J Clin Pharmcol 2003; 59:477-482.